23 Sep 2020

Permira to acquire German pharma firm Neuraxpharm

Private equity firm Permira has agreed to acquire German speciality pharmaceutical company Neuraxpharm from Apax Partners. The companies did not divulge financial details of the transaction. According to Reuters citing…

22 Sep 2020

Bausch Health to acquire ophthalmology assets of Allegro

Bausch Health has signed an agreement to acquire an option to buy biopharmaceutical company Allegro Ophthalmics’ ophthalmological assets. The option will include worldwide rights to Allegro’s lead experimental candidate risuteganib…

21 Sep 2020

Roche acquires biotech firm Inflazome for $449m

Roche has completed a share purchase agreement to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m). Under the deal, Inflazome’s shareholders are eligible for additional milestone…

17 Sep 2020

Palleon Pharmaceuticals secures $100m in Series B funding

Palleon Pharmaceuticals has raised $100m in a Series B financing round to develop drugs targeting glycan-mediated immune regulation to treat cancer and inflammatory diseases. The financing round, led by Matrix…